Purchase Order 75N91024P00272
Award Date 3/12/24
Potential Completion Date 3/11/25
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Sartorius Corporation has been awarded a firm fixed price purchase order totaling $14,900 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for service of the agency's IncuCyte S3 live-cell imaging system located in Bethesda, Maryland, with a period of performance through March 2025. As a manufacturer of laboratory equipment and provider of services to the biopharmaceutical and research industries, Sartorius Corporation...
- Sartorius Corporation has been awarded a firm fixed price purchase order totaling $12,640 by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences. The contract is for the delivery of an INCUCYTE S3 HP VAPOR STERILIZATION system to support biomedical research programs at the agency's location in Bohemia, New York. As a manufacturer of laboratory equipment and services, Sartorius Corporation will serve as the prime...
- The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $15,656.00 firm-fixed-price purchase order to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The service contract is for the Sartorius Incucyte S3, a live-cell analysis system used to support the NCI's biomedical research and development initiatives, particularly in areas such as infectious diseases, cancer, and drug...
- This is a $15,972.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract is for a service agreement to provide the NCI with an IncuCyte S3 Live Cell Analysis System, which is a specialized biomedical instrument used for cutting-edge research in areas such as infectious diseases,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.60 firm fixed price purchase order to Sartorius Corporation for a SERVICE AGREEMENT OF INCUCYTE S3 SW/SVC. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services from their Rockville, Maryland location of performance over a one year period ending in July 2024. No set aside designation or major subcontractors were...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,969.40 contract is for a service agreement to provide the NCI with the S3 IncuCyte live-cell analysis system, which supports cutting-edge biomedical research across infectious diseases, cancer studies, and translational sciences....
- This federal contract awarded to Sartorius Corporation provides one (1) IncuCyte S3 live-cell analysis system for use by the National Cancer Institute's (NCI) Center for Cancer Research (CCR), Oncogenomic Section. The contract, valued at $125,052.76, is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH). The system will support ongoing cancer research at the CCR, including CRISPR-based genetic screens, drug...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.50 firm fixed price purchase order to Sartorius Corporation for preventative maintenance and service of an IncuCyte S3. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services at a location in Bethesda, Maryland through November 2024. The award utilizes a National Institutes of Health contract vehicle to procure services...
- This is a $21,394.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the maintenance of an IncuCyte SX5 live cell imaging system used for real-time cell health and viability measurements to support biomedical research. The award has an ultimate completion date of April 30, 2026 and was not set aside for any specific business type....
- Sartorius Corporation has been awarded a $15,656 firm fixed price purchase order by the National Institutes of Health's National Cancer Institute for maintenance services. The contract has no set-aside designation and requires performance through February 2025 in Bohemia, New York. As a prime contractor and manufacturer of laboratory equipment and consumables, Sartorius Corporation will provide maintenance to support the National Cancer Institute's biomedical research programs. Honeywell...
Sartorius Corporation was awarded a firm fixed-price purchase order totaling $15,656 by the National Institutes of Health's National Cancer Institute to provide an IncuCyte S3 Live Cell Analysis System under a non-set aside contract. As a manufacturer of laboratory equipment and solutions for biopharmaceutical and life sciences research, Sartorius will deliver the biomedical imaging hardware, software, and associated services to support the National Cancer Institute's cell-based research and drug discovery programs. No subcontractors were indicated in the award provided. The contract has a period of performance through March 2025.
Generated 2/27/24, 3:50 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 2/26/24 |